Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...

You have less than a month left to file a claim for part of the $30 million class action settlement.

A 23andMe booth at a genealogical event. The Canadian and British commissioners found the company did not have adequate ...

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...

The California-based company, which allowed customers to learn about their ancestry by submitting saliva samples in the mail, ...

The state of Texas lost its bid for a temporary restraining order to halt the proposed sale of 23andMe’s genetic data bank, ...

Regeneron Pharmaceuticals (NASDAQ:REGN) has reportedly declined to submit a higher bid for 23andMe (OTC:MEHCQ) after a ...

Anne Wojcicki’s winning bid to reclaim control of 23andMe doesn’t necessarily end the fight over what happens to the DNA of ...

The fine comes as the DNA testing firm, which filed for bankruptcy in March, is set to be sold to a new owner.

AndMe had “inadequate” security systems and was “slow to respond” to warning signs customers’ sensitive data was at risk before the "profoundly damaging" hack, officials say.

The ICO has fined genetic testing company 23andMe £2.31 million. It is related to a data breach that impacted the data of 155,592 UK users. The company ...

The fate of 23andMe (MEHCQ) and the treasure trove of data it has on its users is set to be fought over in court. Yahoo ...